Key result
Erratum for mast cell inhibition in AAA corrects collaborator name without providing clinical findings.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Erratum on mast cell inhibition for medium-sized AAA provides no clinical data; leaves open efficacy in dedicated RCTs.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sillesen et al. (2015) studied this question. Mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm lacks clinical findings in the provided abstract, as it is an erratum correcting a collaborator's name.
Synapse has enriched 10 related papers. Consider them for comparative context: